Latest CervoMed News & Updates

See the latest news and media coverage for CervoMed. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
CervoMed

Clinical-stage biotechnology company developing treatments for age-related brain disorders

cervomed.com
Headquarters
Boston, United States
Founded year
2023
Company type
Public company
Number of employees
11–50

Last updated

Latest news about CervoMed

In short: CervoMed reported a $5.9 million Q3 loss and sought a partner for neflamapimod's Phase 3 DLB program.

Company announcements

CervoMed

CervoMed announces initial clinical trial data for neflamapimod in nfvPPA

The twelve-week biomarker findings will be presented at the ISFTD Annual Meeting in October to support ongoing neurodegenerative disease development.

Unlock all announcements with a

Media coverage

Yahoo Finance

CervoMed (CRVO)’s Q4 Results Feature Advancements in Its Neflamapimod Program for Dementia Lewy Bodies (DLB)

CervoMed Inc. (NASDAQ:CRVO) earns a place on our top 10 stocks under $5 that could triple. On March...

Unlock all articles with a

Never miss news about CervoMed

Track CervoMed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.